A Study of the Relationship Between Cystatin C and Metabolic Bone Disease in Preterm Infants

OBJECTIVE: Cystatin C (CysC) is commonly used as a marker of renal failure in premature infants. The aim of this study was to investigate serum CysC levels in osteopenia of prematurity (OP) and determine whether CysC could be safely used as a marker of renal insufficiency in infants with OP. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Korkut, Sabriye, Memur, Şeyma, Halis, Hülya, Baştuğ, Osman, Korkmaz, Levent, Özdemir, Ahmet, Güneş, Tamer, Öztürk, Mehmet Adnan, Kurtoğlu, Selim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985380/
https://www.ncbi.nlm.nih.gov/pubmed/29082894
http://dx.doi.org/10.4274/jcrpe.2088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985380/
https://www.ncbi.nlm.nih.gov/pubmed/29082894
http://dx.doi.org/10.4274/jcrpe.2088

Ejemplares similares